14.24
price up icon0.21%   0.03
after-market Handel nachbörslich: 14.22 -0.02 -0.14%
loading
Schlusskurs vom Vortag:
$14.21
Offen:
$14.2
24-Stunden-Volumen:
515.70K
Relative Volume:
0.37
Marktkapitalisierung:
$11.89B
Einnahmen:
$3.85B
Nettoeinkommen (Verlust:
$667.93M
KGV:
21.67
EPS:
0.657
Netto-Cashflow:
$142.30M
1W Leistung:
+0.78%
1M Leistung:
-2.93%
6M Leistung:
+9.96%
1J Leistung:
-13.69%
1-Tages-Spanne:
Value
$14.12
$14.34
1-Wochen-Bereich:
Value
$14.12
$14.59
52-Wochen-Spanne:
Value
$12.26
$16.77

Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile

Name
Firmenname
Dr Reddys Laboratories Ltd Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
27,811
Name
Twitter
@drreddys
Name
Nächster Verdiensttermin
2025-07-23
Name
Neueste SEC-Einreichungen
Name
RDY's Discussions on Twitter

Vergleichen Sie RDY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
RDY
Dr Reddys Laboratories Ltd Adr
14.24 11.83B 3.85B 667.93M 142.30M 0.657
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
155.37 68.60B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.86 46.99B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.71 43.17B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.05 20.82B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
305.35 13.98B 2.99B 1.21B 1.13B 25.06

Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-05 Hochstufung HSBC Securities Hold → Buy
2024-12-19 Herabstufung Nomura Buy → Neutral
2024-01-11 Herabstufung Jefferies Buy → Underperform
2023-08-29 Herabstufung HSBC Securities Buy → Hold
2023-05-18 Herabstufung Bernstein Outperform → Mkt Perform
2023-03-17 Hochstufung BofA Securities Neutral → Buy
2023-01-30 Eingeleitet JP Morgan Underweight
2022-11-14 Herabstufung Credit Suisse Neutral → Underperform
2022-01-03 Fortgesetzt BofA Securities Neutral
2021-07-27 Herabstufung Credit Suisse Outperform → Neutral
2021-02-02 Hochstufung Barclays Equal Weight → Overweight
2020-09-18 Hochstufung BofA Securities Neutral → Buy
2020-09-18 Hochstufung Investec Sell → Hold
2020-01-28 Herabstufung CLSA Buy → Outperform
2020-01-27 Herabstufung CLSA Buy → Outperform
2020-01-09 Hochstufung Citigroup Sell → Buy
2019-11-04 Herabstufung BofA/Merrill Buy → Neutral
2019-09-04 Hochstufung Credit Suisse Underperform → Outperform
2019-07-01 Hochstufung Macquarie Neutral → Outperform
2019-06-20 Eingeleitet Deutsche Bank Hold
2019-06-11 Eingeleitet Barclays Equal Weight
2019-05-20 Herabstufung Morgan Stanley Overweight → Equal-Weight
2019-02-19 Hochstufung CLSA Outperform → Buy
2019-01-17 Herabstufung Citigroup Neutral → Sell
2017-09-21 Hochstufung Morgan Stanley Equal-Weight → Overweight
2017-08-31 Hochstufung CLSA Underperform → Outperform
2017-07-28 Herabstufung CLSA Underperform → Sell
2016-07-27 Herabstufung HSBC Securities Hold → Reduce
2016-07-27 Herabstufung Jefferies Hold → Underperform
2016-02-10 Hochstufung Credit Agricole Underperform → Buy
2015-11-10 Herabstufung Citigroup Buy → Neutral
Alle ansehen

Dr Reddys Laboratories Ltd Adr Aktie (RDY) Neueste Nachrichten

pulisher
Aug 25, 2025

Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) - Barchart.com

Aug 25, 2025
pulisher
Aug 20, 2025

Asian ADRs Trade Lower As S&P Asia 50 Index Drops - Finimize

Aug 20, 2025
pulisher
Aug 18, 2025

Asian Tech Names Lift US-Traded Stocks To A Small Gain - Finimize

Aug 18, 2025
pulisher
Aug 13, 2025

LLY Stock Quote Price and Forecast - CNN

Aug 13, 2025
pulisher
Aug 06, 2025

Trump Tariff Impact: Infosys, Wipro, HDFC Bank, Other ADR Shares Drop After US Levies 50% Tariff On India - MSN

Aug 06, 2025
pulisher
Aug 06, 2025

Asian Stocks In The US See Mixed Moves Across Sectors - Finimize

Aug 06, 2025
pulisher
Aug 06, 2025

Trump hikes tariffs on India by additional 25% citing Russian oil trade; iShares India ETF, ADRs react - Moneycontrol

Aug 06, 2025
pulisher
Aug 06, 2025

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT - GlobeNewswire Inc.

Aug 06, 2025
pulisher
Aug 02, 2025

Asian ADRs Fall As Winners And Losers Stand Out - Finimize

Aug 02, 2025
pulisher
Jul 31, 2025

Asian ADRs Falter On US Markets As Fintechs Slide - Finimize

Jul 31, 2025
pulisher
Jul 30, 2025

Trump Tariff Impact: Infosys, Wipro, HDFC Bank, Other ADR Shares Drop After US Levies 25% Tariff On India - MSN

Jul 30, 2025
pulisher
Jul 29, 2025

NVO Stock Quote Price and Forecast - CNN

Jul 29, 2025
pulisher
Jul 29, 2025

Asian Stocks Listed In The US Kicked Off The Week Lower - Finimize

Jul 29, 2025
pulisher
Jul 28, 2025

Validea's Top Health Care Stocks Based On Peter Lynch7/28/2025 - Nasdaq

Jul 28, 2025
pulisher
Jul 25, 2025

Asian Stocks Dipped As US-Listed ADRs Edged Lower - Finimize

Jul 25, 2025
pulisher
Jul 24, 2025

From Infosys, IndusInd Bank to Natco Pharma, 9 stocks to watch today - financialexpress.com

Jul 24, 2025
pulisher
Jul 23, 2025

Stock Picks Today: Infosys, Dr. Reddys Labs, Kajaria Ceramics, Tata Consumer Products On Brokerages Radar - NDTV Profit

Jul 23, 2025
pulisher
Jul 23, 2025

Asian Stocks Mixed As S&P Asia 50 ADR Index Falls - Finimize

Jul 23, 2025
pulisher
Jul 23, 2025

Dr Reddy's Q1 Results Preview: Analysts Outlook Mixed, See Double-Digit Growth - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Dr. Reddy’s Labs ADR earnings missed, revenue fell short of estimates - Investing.com Australia

Jul 23, 2025
pulisher
Jul 23, 2025

India's Dr Reddy's says open to boosting U.S. manufacturing as tariff threat looms - sg.finance.yahoo.com

Jul 23, 2025
pulisher
Jul 23, 2025

Q1 Results Highlights: Infosys net profit rises 9%, Tata Consumer revenue jumps 10% - Moneycontrol

Jul 23, 2025
pulisher
Jul 22, 2025

Dr Reddys Q1 Results Preview: Analysts Outlook Mixed, See Double-Digit Growth - NDTV Profit

Jul 22, 2025
pulisher
Jul 18, 2025

HSBC Upgrades Dr. Reddy’s Laboratories Limited (RDY) to Buy from Hold - MSN

Jul 18, 2025
pulisher
Jul 16, 2025

Asian ADRs Retreat As Mixed Results Hit The Market - Finimize

Jul 16, 2025
pulisher
Jul 14, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Jul 14, 2025
pulisher
Jul 14, 2025

Morgan Stanley initiates coverage on Dr. Reddy’s stock with Equalweight rating - Investing.com India

Jul 14, 2025
pulisher
Jul 10, 2025

Dr Reddy's Laboratories among four key stocks to trade ex-dividend today - Mint

Jul 10, 2025
pulisher
Jul 09, 2025

Allspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy’s Laboratories Ltd (NYSE:RDY) - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Trump Tariffs: Dr Reddys To Lupin — Pharma Stocks To Be In Focus After Threat Of 200% Levies - NDTV Profit

Jul 09, 2025

Finanzdaten der Dr Reddys Laboratories Ltd Adr-Aktie (RDY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$10.42
price up icon 0.10%
$138.13
price up icon 0.94%
$305.35
price down icon 1.25%
$18.49
price up icon 3.30%
$29.25
price up icon 0.93%
Kapitalisierung:     |  Volumen (24h):